Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Opsens Inc.
  6. News
  7. Summary
    OPS   CA6838231083

OPSENS INC.

(OPS)
  Report
Delayed Toronto Stock Exchange  -  05/18 04:00:00 pm EDT
1.760 CAD   -3.30%
09:12aOpsens Announces Publication of New Optowire Data in Journal
MT
08:48aOpsens announces publication in jscai of data supporting the correlation between the optowire and a novel tavr interface with standard of care, before and after tavr
AQ
04/26OpSens Announces Health Canada Approval For Its New TAVR Guidewire
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Opsens : Initiated At Outperform By Raymond James

02/01/2021 | 08:24am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
All news about OPSENS INC.
09:12aOpsens Announces Publication of New Optowire Data in Journal
MT
08:48aOpsens announces publication in jscai of data supporting the correlation between the op..
AQ
04/26OpSens Announces Health Canada Approval For Its New TAVR Guidewire
MT
04/26Opsens announces health canada approval for its new tavr guidewire
AQ
04/26Opsens Inc. Announces Health Canada Approval for Its New TAVR Guidewire
CI
04/13TRANSCRIPT : Opsens Inc., Q2 2022 Earnings Call, Apr 13, 2022
CI
04/13OPSENS : CEO Certification
PU
04/13OPSENS : CFO Certification
PU
04/13Opsens Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Februa..
CI
04/13OpSens Swings to Loss in Fiscal Q2 as Consolidated Sales Drop
MT
More news
Analyst Recommendations on OPSENS INC.
More recommendations
Financials
Sales 2022 36,6 M 28,5 M 28,5 M
Net income 2022 -7,29 M -5,67 M -5,67 M
Net Debt 2022 - - -
P/E ratio 2022 -26,1x
Yield 2022 -
Capitalization 191 M 148 M 148 M
Capi. / Sales 2022 5,22x
Capi. / Sales 2023 3,51x
Nbr of Employees 163
Free-Float 95,0%
Chart OPSENS INC.
Duration : Period :
Opsens Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPSENS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 1,76 CAD
Average target price 4,22 CAD
Spread / Average Target 140%
EPS Revisions
Managers and Directors
Louis Laflamme President, Chief Executive Officer & Director
Robin Villeneuve Chief Financial Officer & Secretary
Alan W. Milinazzo Executive Chairman
Jean Lavigueur Independent Director
Denis L. Harrington Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OPSENS INC.-41.29%154
THERMO FISHER SCIENTIFIC-19.16%217 105
DANAHER CORPORATION-24.33%178 236
INTUITIVE SURGICAL, INC.-37.33%80 830
SIEMENS HEALTHINEERS AG-14.68%66 343
EDWARDS LIFESCIENCES CORPORATION-24.82%60 552